These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33982141)

  • 1. Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial.
    Rung JM; Horta M; Tammi EM; Perez E; Ojeda MC; Lin T; Harris G; Somerville J; Salmeron D; Beltz SE; Sandesara B; Feifel D; Ebner NC
    Psychopharmacology (Berl); 2021 Sep; 238(9):2405-2418. PubMed ID: 33982141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up.
    Alaerts K; Steyaert J; Vanaudenaerde B; Wenderoth N; Bernaerts S
    Eur Neuropsychopharmacol; 2021 Feb; 43():147-152. PubMed ID: 33309460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four-week intranasal oxytocin administration reduces attachment avoidance in older women.
    Wright KA; Polk R; Lin T; Feifel D; Ebner NC
    Horm Behav; 2023 Sep; 155():105413. PubMed ID: 37659357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic intranasal oxytocin on visual attention to faces vs. natural scenes in older adults.
    Shoenfelt A; Pehlivanoglu D; Lin T; Ziaei M; Feifel D; Ebner NC
    Psychoneuroendocrinology; 2024 Jun; 164():107018. PubMed ID: 38461634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia : an 8-week, randomized, double-blind, placebo-controlled study.
    Modabbernia A; Rezaei F; Salehi B; Jafarinia M; Ashrafi M; Tabrizi M; Hosseini SM; Tajdini M; Ghaleiha A; Akhondzadeh S
    CNS Drugs; 2013 Jan; 27(1):57-65. PubMed ID: 23233269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study.
    Daughters K; Manstead AS; Hubble K; Rees A; Thapar A; van Goozen SH
    PLoS One; 2015; 10(12):e0145104. PubMed ID: 26669935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary and plasma oxytocin changes in response to MDMA or intranasal oxytocin administration.
    Francis SM; Kirkpatrick MG; de Wit H; Jacob S
    Psychoneuroendocrinology; 2016 Dec; 74():92-100. PubMed ID: 27592327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal oxytocin in the treatment of anorexia nervosa: Randomized controlled trial during re-feeding.
    Russell J; Maguire S; Hunt GE; Kesby A; Suraev A; Stuart J; Booth J; McGregor IS
    Psychoneuroendocrinology; 2018 Jan; 87():83-92. PubMed ID: 29049935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a 10-day oxytocin trial in older adults on health and well-being.
    Barraza JA; Grewal NS; Ropacki S; Perez P; Gonzalez A; Zak PJ
    Exp Clin Psychopharmacol; 2013 Apr; 21(2):85-92. PubMed ID: 23421352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.
    Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term oxytocin administration enhances the experience of attachment.
    Bernaerts S; Prinsen J; Berra E; Bosmans G; Steyaert J; Alaerts K
    Psychoneuroendocrinology; 2017 Apr; 78():1-9. PubMed ID: 28131072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability.
    Finger EC; MacKinley J; Blair M; Oliver LD; Jesso S; Tartaglia MC; Borrie M; Wells J; Dziobek I; Pasternak S; Mitchell DG; Rankin K; Kertesz A; Boxer A
    Neurology; 2015 Jan; 84(2):174-81. PubMed ID: 25503617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a placebo-controlled, within-participants crossover trial evaluating the efficacy of intranasal oxytocin to improve pain and function among women with chronic pelvic musculoskeletal pain.
    Rash JA; Toivonen K; Robert M; Nasr-Esfahani M; Jarrell JF; Campbell TS
    BMJ Open; 2017 Apr; 7(4):e014909. PubMed ID: 28416501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders.
    Tachibana M; Kagitani-Shimono K; Mohri I; Yamamoto T; Sanefuji W; Nakamura A; Oishi M; Kimura T; Onaka T; Ozono K; Taniike M
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):123-7. PubMed ID: 23480321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic Effects of Chronic Intranasal Oxytocin on Neural Responses to Threat Are Dose-Frequency Dependent.
    Kou J; Zhang Y; Zhou F; Gao Z; Yao S; Zhao W; Li H; Lei Y; Gao S; Kendrick KM; Becker B
    Psychother Psychosom; 2022; 91(4):253-264. PubMed ID: 35086102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder.
    Greene RK; Spanos M; Alderman C; Walsh E; Bizzell J; Mosner MG; Kinard JL; Stuber GD; Chandrasekhar T; Politte LC; Sikich L; Dichter GS
    J Neurodev Disord; 2018 Mar; 10(1):12. PubMed ID: 29587625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome.
    Hall SS; Lightbody AA; McCarthy BE; Parker KJ; Reiss AL
    Psychoneuroendocrinology; 2012 Apr; 37(4):509-18. PubMed ID: 21862226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial.
    Quintana DS; Westlye LT; Alnæs D; Rustan ØG; Kaufmann T; Smerud KT; Mahmoud RA; Djupesland PG; Andreassen OA
    Psychoneuroendocrinology; 2016 Jul; 69():180-8. PubMed ID: 27107209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Intranasal Oxytocin on Stress-Induced Cigarette Craving in Daily Smokers.
    Van Hedger K; Bershad AK; Lee R; de Wit H
    Nicotine Tob Res; 2020 Jan; 22(1):89-95. PubMed ID: 30085292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.
    Acheson DT; Feifel D; Kamenski M; Mckinney R; Risbrough VB
    Depress Anxiety; 2015 Jun; 32(6):400-7. PubMed ID: 25826649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.